Electromed Inc(ELMD) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | 21.2 | EPS (ttm) | 1.3 | Insider Own | 17.05% | Shs Outstand | 8.4M | Perf Week | 4.87% |
| Market Cap | 0.23B | Forward P/E | 16.31 | EPS next Y | 16.15% | Insider Trans | -4.13% | Shs Float | 6.9M | Perf Month | -30.11% |
| Enterprise Value | 0.21B | PEG | 0.95 | EPS next Q | 0.26 | Inst Own | 59.23% | Short Float | 2.64% | Perf Quarter | -28.45% |
| Income | 0.01B | P/S | 3.13 | EPS this Y | 11.92% | Inst Trans | -0.39% | Short Ratio | 1.68 | Perf Half Y | 12.58% |
| Sales | 0.07B | P/B | 4.27 | EPS next 5Y | 17.15% | ROA | 18.53% | Short Interest | 0.18M | Perf YTD | -5.32% |
| Book/sh | 6.45 | P/C | 11.28 | EPS past 3/5Y | 52.9% 37.46% | ROE | 23.26% | 52W High | -41.84% ($47.40) | Perf Year | 10.86% |
| Cash/sh | 2.44 | P/FCF | 27.43 | Sales past 3/5Y | 15.35% 15.59% | ROIC | 20.91% | 52W Low | 19.82% ($23.01) | Perf 3Y | 156.47% |
| Dividend Est. | - | EV/EBITDA | 14.06 | EPS Y/Y TTM | 53.24% | Gross Margin | 78.54% | Volatility(W/M) | 4.05% 5.62% | Perf 5Y | 121.98% |
| Dividend TTM | - | EV/Sales | 2.85 | Sales Y/Y TTM | 15.28% | Oper. Margin | 18.82% | ATR (14) | 1.45 | Perf 10Y | 512.67% |
| Dividend Ex-Date | - | Quick Ratio | 4.39 | EPS Q/Q | 54.03% | Profit Margin | 15.32% | RSI (14) | 33.35 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.69 | Sales Q/Q | 11.64% | SMA20 | -2.33% ($28.23) | Beta | 0.4 | Target Price | $48.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/8/25 | SMA50 | -23.31% ($35.95) | Rel Volume | 1.36 | Prev Close | $27 |
| Employees | 197 | LT Debt/Eq | 0 | EPS/Sales Surpr. | 23.14% 0.43% | SMA200 | -12.28% ($31.43) | Avg Volume(3M) | 0.11M | Price | $27.57 |
| IPO | 2010/8/13 | Option/Short | Yes/Yes | Trades | 2354 | Volume | 148,322 | Change | 2.11% |
Company
ELMD is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🫁 Electromed (ELMD) is a U.S. medical device company that develops, manufactures, and sells airway clearance therapy devices using high-frequency chest wall oscillation (HFCWO) technology. Its flagship product, the SmartVest System, is a non-invasive therapy device designed to help patients with chronic respiratory conditions, such as bronchiectasis, clear mucus at home. The company considers its direct-to-patient sales model a key competitive strength.
Over the past 1 year, on the lower side
42% below its 1-year high.
ELMD makes money exceptionally well
18.82% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +11.9% this year.
Tap to view numbers
The price looks about right
Trading at 21.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +156.5% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 59.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DWAS 0.00%
ROSC 0.00%
SQLV 0.00%
FSEG 0.00%
SMLV 0.00%It ranks #4 in the industry
Based on market cap of $231M.
ELMD $231M PER 21.2
ABT $179B PER 33.5
MDT $116B PER 22.4
SYK $106B PER 28.5
FAQ
What kind of company is ELMD?
ELMD belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of ELMD?
The market cap of ELMD is approximately $231M, ranking 4,006 within its sector.
What is the P/E ratio of ELMD?
ELMD has a P/E ratio of approximately 21.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for ELMD?
ELMD has recorded a 52-week high of $47.40 and a low of $23.01.
